150691-04-6

Basic information

• Product Name: 2-(tert-Butylamino)sulfonylphenylboronic acid
• Synonyms: AKOS BRN-0531;2-(T-BUTYLAMINO)SULFONYLPHENYLBORONIC ACID;(2-((TERT-BUTYLAMINO)SULFANYL)PHENYL) BORONIC ACID;2-(TERT-BUTYLAMINO)SULFONYLPHENYLBORONIC ACID;CHEMBRDG-BB 3200963;{2-[(tert-butylamino)sulfonyl]phenyl}boronic acid(SALTDATA: FREE);(2-(N-(tert-Butyl)sulfamoyl)phenyl)boronic acid;N-TERT-BUTYLBENZENESULFONAMIDE-2-BORONIC ACID
• CAS NO: 150691-04-6
• Molecular Formula: C₁₀H₁₆BNO₄S
• Molecular Weight: 257.11
• Product Categories: Aryl;Organoborons;Sulfonamide
• Mol File: 150691-04-6.mol
• Article Data: 20

Chemical Properties

• Melting Point: 118-119 °C
• Boiling Point: 443.205 °C at 760 mmHg
• Flash Point: 221.843 °C
• Appearance: /
• Density: 1.283 g/cm³
• Vapor Pressure: 1.23E-08mmHg at 25°C
• Refractive Index: 1.554
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 8.00±0.53(Predicted)
• CAS DataBase Reference: 2-(tert-Butylamino)sulfonylphenylboronic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(tert-Butylamino)sulfonylphenylboronic acid(150691-04-6)
• EPA Substance Registry System: 2-(tert-Butylamino)sulfonylphenylboronic acid(150691-04-6)

Safety Data

• Hazardous Substances Data: 150691-04-6(Hazardous Substances Data)

Usage

Description

2-(tert-Butylamino)sulfonylphenylboronic acid is a boronic acid derivative with the molecular formula C10H16BNO4S. It features a boron atom attached to a phenyl ring and a sulfonamide group, with a tert-butylamino group providing steric hindrance at the boron center. 2-(tert-Butylamino)sulfonylphenylboronic acid is known for its reactivity and stability in organic synthesis, particularly in forming carbon-carbon and carbon-heteroatom bonds.

Uses

Used in Organic Synthesis:
2-(tert-Butylamino)sulfonylphenylboronic acid is used as a reagent in organic synthesis for the formation of carbon-carbon and carbon-heteroatom bonds. Its unique structure and reactivity make it a valuable component in creating complex organic molecules.
Used in Pharmaceutical Development:
In the pharmaceutical industry, 2-(tert-Butylamino)sulfonylphenylboronic acid is used as a building block or intermediate in the synthesis of various drug candidates. Its potential applications include the development of new therapeutic agents and the improvement of existing medications.
Used as a Ligand in Catalytic Reactions:
2-(tert-Butylamino)sulfonylphenylboronic acid is utilized as a ligand in catalytic reactions, enhancing the efficiency and selectivity of various chemical transformations. Its presence can improve the performance of catalysts and facilitate specific reaction pathways.
Used in Optoelectronic Materials Development:
In the optoelectronics industry, 2-(tert-Butylamino)sulfonylphenylboronic acid is used in the development of materials for optoelectronic devices. Its properties contribute to the creation of advanced materials with improved performance in areas such as solar cells, light-emitting diodes, and photodetectors.

InChI:InChI=1/C10H16BNO4S/c1-10(2,3)12-17(15,16)9-7-5-4-6-8(9)11(13)14/h4-7,12-14H,1-3H3

Upstream product

• 98-09-9 benzenesulfonyl chloride 
• 121-43-7 Trimethyl borate 
• 2512-24-5 N-tert-butylbenzenesulfonamide 
• 5419-55-6 Triisopropyl borate 

Downstream Products

• 218302-19-3 2-(6-amino-3-pyrimidinyl)benzene-tert-butylsulfonamide 
• 903876-81-3 4'-[1-(4-methoxy-phenyl)-4-methyl-7-oxo-3-trifluoromethyl-1,7-dihydro-pyrazolo[3,4-d]pyridazin-6-yl]-biphenyl-2-sulfonic acid tert-butylamide 
• 280119-52-0 6-(2'-tert-butylsulfamoyl-3-fluoro-biphenyl-4-yl)-1-(4-methoxy-phenyl)-7-oxo-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidine-3-carboxylic acid methyl ester 
• 280119-60-0 6-(2'-tert-butylsulfamoyl-biphenyl-4-yl)-1-(4-methoxy-phenyl)-7-oxo-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidine-3-carboxylic acid methyl ester 
• 745794-59-6 2-O-benzyl-5-O-[3'-(2''-tert-butylaminosulfonylphenyl)phenyl]-1,4:3,6-dianhydro-D-mannitole 
• 745794-62-1 2-O-[4'-(2''-tert-butylaminosulfonylphenyl)benzyl]-1,4:3,6-dianhydro-D-mannitole 
• 634610-83-6 2-O-benzyl-5-O-[4'-(2''-tert-butylamino-sulfonylphenyl)-phenyl]-1,4:3,6-dianhydro-D-mannitol 
• 477717-00-3 methyl 4-(2'-tert-butylaminosulfonyl)phenyl-2-methyl benzoate 
• 316364-80-4 1N-(4'-(o-tert-butylaminosulfonylphenyl)phenylcarbonyl)methyl-6-cyanobenzimidazole 
• 1026901-65-4 2-(5-amino-pyridin-2-yl)-N-tert-butyl-benzenesulfonamide 
• 203512-83-8 2-Amino-5-(2-t-butylaminosulfonyl-phenyl)-pyridine 

Relevant articles and documents

BENZOXAZEPIN COMPOUNDS SELECTIVE FOR PI3K P110 DELTA AND METHODS OF USE

Benzoxazepin Formula I compounds, including stereoisomers, geometric isomers, tautomers, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting the delta isoform of PI3K, and for treating disorders mediated by lipid kinases such as inflammation, immunological disorders, and cancer. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.

Design and synthesis of cyclic sulfonamides and sulfamates as new calcium sensing receptor agonists

The design, synthesis and calcimimetic properties of various cyclic sulfonamides and sulfamates are described. The latter were prepared from the corresponding o-alkenylarenesulfonamides via copper- or rhodium-catalyzed intramolecular aziridination. The si

THIOUREAS AS FACTOR Xa INHIBITORS

The present invention is directed to compounds represented by Formula (I) and pharmaceutically acceptable salts, solvates, hydrates, and prodrugs thereof which are inhibitors of Factor Xa. The present invention is also directed to and intermediates used in making such compounds, pharmaceutical compositions containing such compounds, methods to prevent or treat a number of conditions characterized by undesired thrombosis and methods of inhibiting the coagulation of a blood sample.